|
시장보고서
상품코드
2055046
리포좀 시장 : 유형별, 구조별, 지질 조성별, 제조 방법별, 약물 탑재 방법별, 용도별, 투여 경로별, 최종사용자별, 지역별Liposomes Market, By Type, By Structure, By Lipid Composition, By Technique of Preparation, By Drug Loading Method, By Application, By Route of Administration, By End User, By Geography |
||||||
리포좀 시장은 2026년에 58억 6,000만 달러로 추정되며, 2033년에 112억 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 9.7%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 58억 6,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026-2033년까지 예측 기간 CAGR: | 9.70% | 2033년 시장 규모 예측: | 112억 달러 |
세계 리포좀 시장은 의약품 및 생명공학 산업에서 급속히 발전하고 있는 분야로, 치료 효과를 높이기 위해 인지질 기반 소포 구조를 활용한 첨단 약물전달 시스템을 특징으로 합니다.
생체적합성과 생분해성을 갖춘 운반체인 리포좀은 생체이용률을 대폭 향상시키면서 부작용을 최소화하는 표적 약물전달 메커니즘을 제공함으로써 제약 산업에 혁명을 일으켰습니다. 수성 코어를 둘러싼 하나 이상의 인지질 이중층으로 구성된 이 미세한 구형 소포는, 친수성 및 친유성 약물, 단백질, 펩타이드, 유전 물질을 캡슐화하기 위한 범용성이 높은 플랫폼으로 기능합니다.
시장 확대는 만성 질환 유병률의 증가, 맞춤형 의료에 대한 수요 증가, 나노기술을 활용한 약물전달 시스템에 대한 대규모 투자에 힘입어 이루어지고 있습니다. 종양학, 감염증, 안과, 백신 개발 등 폭넓은 분야에서 활용되고 있는 리포좀은 다양한 의료 분야에서 치료 성과를 향상시키는 데 있어 놀라운 가능성을 보여주고 있습니다.
첨단 제조 기술의 통합과 더불어 혁신적인 리포좀 제제에 대한 규제 당국의 승인이 더해지면서, 이 시장은 현대 의약품 개발 전략의 핵심 요소로서의 입지를 확고히 하고 있으며, 차세대 약물전달 솔루션을 활용하려는 기존 제약사와 신생 바이오기술 기업 모두로부터 큰 주목을 받고 있습니다.
시장 역학
전 세계 리포좀 시장은 몇 가지 강력한 촉진요인에 힘입어 성장하고 있습니다. 그 주요 원인은 전 세계적으로 암 및 만성 질환의 유병률이 증가하고 있다는 점이며, 이에 대응하기 위해서는 리포좀 제제가 독보적인 방식으로 제공하는, 보다 효과적이고 표적화된 치료적 개입이 필요합니다. 고령 인구 증가에 더해, 의료비 증가와 첨단 약물전달 메커니즘에 대한 인식 제고 또한 시장 확대에 크게 기여하고 있습니다.
원격 전달 기술 및 스텔스 리포좀 개발 등 리포좀 제조 공정의 기술적 진보로 인해 제품의 안정성과 치료 효과가 향상되면서, 각 제약사가 리포좀 제제에 막대한 투자를 하도록 촉진하고 있습니다. 그러나 시장에는 리포좀 제품과 관련된 높은 개발 및 제조 비용, 시장 출시까지의 기간을 연장시키는 복잡한 규제 승인 절차, 제품의 품질과 일관성을 유지하면서 생산 규모를 확대할 때 발생하는 기술적 과제 등 뚜렷한 제약요인이 존재합니다.
기존 리포좀 제제의 특허 만료와 대체 약물전달 시스템으로부터의 치열한 경쟁 또한 또 다른 과제로 대두되고 있습니다. 이러한 제약이 있음에도 불구하고, 유전자 치료, 백신 개발, 맞춤형 의료 분야에서의 리포좀 응용 확대에 따라 큰 기회가 창출되고 있습니다.
희귀 질환 치료에 대한 관심 증가, 신흥 시장에서의 리포좀 제제 채택 확대, 화장품 및 영양 보조 식품 분야로의 잠재적 응용은 수익성 높은 성장 경로를 제시하고 있습니다. 제약 회사와 연구 기관 간의 전략적 제휴, 그리고 나노기술 연구를 지원하는 정부의 노력은 리포좀 약물전달 시스템 분야의 시장 확대와 혁신을 위한 유리한 여건을 조성하고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 리포좀 시장의 주요 기업 개요을 작성했습니다. 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대, 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 전 세계 리포좀 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 리포좀 시장을 분석하는 데 사용되는 다양한 전략 매트릭스를 통해 의사결정을 수월하게 내릴 수 있습니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 리포좀 시장 : 유형별, 2021-2033년
제5장 세계의 리포좀 시장 : 구조별, 2021-2033년
제6장 세계의 리포좀 시장 : 지질 조성별, 2021-2033년
제7장 세계의 리포좀 시장 : 제조 방법별, 2021-2033년
제8장 세계의 리포좀 시장 : 약물 탑재 방법별, 2021-2033년
제9장 세계의 리포좀 시장 : 용도별, 2021-2033년
제10장 세계의 리포좀 시장 : 투여 경로별, 2021-2033년
제11장 세계의 리포좀 시장 : 최종사용자별, 2021-2033년
제12장 세계의 리포좀 시장 : 지역별, 2021-2033년
제13장 경쟁 구도
제14장 애널리스트의 제안
제15장 참고문헌과 조사 방법
KSM 26.06.18Liposomes Market is estimated to be valued at USD 5.86 Bn in 2026 and is expected to reach USD 11.20 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5.86 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.70% | 2033 Value Projection: | USD 11.20 Bn |
The global liposomes market represents a rapidly evolving segment within the pharmaceutical and biotechnology industries, characterized by sophisticated drug delivery systems that leverage phospholipid-based vesicular structures to enhance therapeutic efficacy.
Liposomes, as biocompatible and biodegradable carriers, have revolutionized the pharmaceutical landscape by offering targeted drug delivery mechanisms that significantly improve bioavailability while minimizing adverse effects. These microscopic spherical vesicles, composed of one or more phospholipid bilayers surrounding an aqueous core, serve as versatile platforms for encapsulating both hydrophilic and lipophilic drugs, proteins, peptides, and genetic materials.
The market's expansion is driven by increasing prevalence of chronic diseases, growing demand for personalized medicine, and substantial investments in nanotechnology-based drug delivery systems. With applications spanning oncology, infectious diseases, ophthalmology, and vaccine development, liposomes have demonstrated remarkable potential in enhancing therapeutic outcomes across diverse medical fields.
The integration of advanced manufacturing technologies, coupled with regulatory approvals for innovative liposomal formulations, has positioned this market as a critical component of modern pharmaceutical development strategies, attracting significant attention from both established pharmaceutical companies and emerging biotechnology firms seeking to capitalize on next-generation drug delivery solutions.
Market Dynamics
The global liposomes market is propelled by several compelling drivers, primarily the escalating prevalence of cancer and chronic diseases worldwide, which necessitates more effective and targeted therapeutic interventions that liposomal drug delivery systems uniquely provide. The growing geriatric population, coupled with increasing healthcare expenditure and rising awareness about advanced drug delivery mechanisms, significantly contributes to market expansion.
Technological advancements in liposome manufacturing processes, including remote loading techniques and stealth liposome development, have enhanced product stability and therapeutic efficacy, driving pharmaceutical companies to invest heavily in liposomal formulations. However, the market faces notable restraints including high development and manufacturing costs associated with liposomal products, complex regulatory approval processes that extend time-to-market, and technical challenges related to scale-up production while maintaining product quality and consistency.
Patent expirations of established liposomal drugs and intense competition from alternative drug delivery systems pose additional challenges. Despite these constraints, significant opportunities emerge from the expanding applications of liposomes in gene therapy, vaccine development, and personalized medicine sectors.
The growing focus on rare disease treatments, increasing adoption of liposomal formulations in emerging markets, and potential applications in cosmetics and nutraceuticals present lucrative growth avenues. Strategic collaborations between pharmaceutical companies and research institutions, along with government initiatives supporting nanotechnology research, create favorable conditions for market expansion and innovation in liposomal drug delivery systems.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global liposomes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Gilead Sciences, Johnson and Johnson, Sun Pharmaceutical Industries, Pacira BioSciences, Luye Pharma Group, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Novartis, Ipsen, Bristol Myers Squibb, Pfizer, Merck, Evonik Health Care, Fujifilm, and Polymun Scientific
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global liposomes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global liposomes market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2021 - 2033)
- Conventional Liposomes
- PEGylated Liposomes
- Ligand-Targeted Liposomes
- Long-Circulating (Stealth) Liposomes
- pH-Sensitive Liposomes
- Temperature-Sensitive Liposomes
- Cationic Liposomes
- Structure Insights (Revenue, USD Bn, 2021 - 2033)
- Multilamellar Vesicles
- Small Unilamellar Vesicles
- Large Unilamellar Vesicles
- Giant Unilamellar Vesicles
- Lipid Composition Insights (Revenue, USD Bn, 2021 - 2033)
- Phospholipid-Based Liposomes
- Cholesterol-Enriched Liposomes
- Sphingomyelin-Based Liposomes
- Synthetic Lipid Liposomes (DSPC, DOPC, others)
- Natural Lipid Liposomes
- Technique of Preparation Insights (Revenue, USD Bn, 2021 - 2033)
- Thin Film Hydration
- Reverse-Phase Evaporation
- Ethanol Injection
- Microfluidics-Based Production
- Detergent Removal
- Freeze-Thaw Method
- High-Pressure Homogenization
- Drug Loading Method Insights (Revenue, USD Bn, 2021 - 2033)
- Passive Loading
- Active Loading (pH Gradient, Ammonium Sulfate Gradient)
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Drug Delivery
- Oncology
- Infectious Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Dermatology
- Gene Delivery
- Vaccine Delivery
- Cosmetics and Personal Care
- Nutraceuticals
- Diagnostics and Imaging
- Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Intravenous
- Intramuscular
- Subcutaneous
- Oral
- Topical
- Inhalation
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Hospitals and Clinics
- Cosmetics and Personal Care Manufacturers
- Contract Research and Manufacturing Organizations (CROs/CMOs)
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Gilead Sciences
- Johnson and Johnson
- Sun Pharmaceutical Industries
- Pacira BioSciences
- Luye Pharma Group
- Takeda Pharmaceutical Company
- Teva Pharmaceutical Industries
- Novartis
- Ipsen
- Bristol Myers Squibb
- Pfizer
- Merck
- Evonik Health Care
- Fujifilm
- Polymun Scientific
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Liposomes Market, By Type
- Global Liposomes Market, By Structure
- Global Liposomes Market, By Lipid Composition
- Global Liposomes Market, By Technique of Preparation
- Global Liposomes Market, By Drug Loading Method
- Global Liposomes Market, By Application
- Global Liposomes Market, By Route of Administration
- Global Liposomes Market, By End User
- Global Liposomes Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Liposomes Market, By Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Conventional Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- PEGylated Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ligand-Targeted Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Long-Circulating (Stealth) Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- pH-Sensitive Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Temperature-Sensitive Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cationic Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Liposomes Market, By Structure, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Multilamellar Vesicles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Small Unilamellar Vesicles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Large Unilamellar Vesicles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Giant Unilamellar Vesicles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Liposomes Market, By Lipid Composition, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Phospholipid-Based Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cholesterol-Enriched Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Sphingomyelin-Based Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Synthetic Lipid Liposomes (DSPC, DOPC, others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Natural Lipid Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Liposomes Market, By Technique of Preparation, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Thin Film Hydration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Reverse-Phase Evaporation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ethanol Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Microfluidics-Based Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Detergent Removal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Freeze-Thaw Method
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- High-Pressure Homogenization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Liposomes Market, By Drug Loading Method, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Passive Loading
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Active Loading (pH Gradient, Ammonium Sulfate Gradient)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Liposomes Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Drug Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Gene Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Vaccine Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cosmetics and Personal Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Nutraceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostics and Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Liposomes Market, By Route of Administration, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Inhalation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
11. Global Liposomes Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cosmetics and Personal Care Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Contract Research and Manufacturing Organizations (CROs/CMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
12. Global Liposomes Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Structure, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Structure, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Structure, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Structure, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Structure, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Structure, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
13. Competitive Landscape
- Gilead Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson and Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pacira BioSciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Luye Pharma Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ipsen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Evonik Health Care
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fujifilm
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Polymun Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
14. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
15. References and Research Methodology
- References
- Research Methodology
- About us
